Tumor Ablation Market—Forecast till 2030
Description
Tumor Ablation Market—Forecast till 2030
Tumor Ablation Market—Forecast till 2030
Market Overview
As per the MRFR analysis, the global tumor ablation market is estimated to witness a notable CAGR of 11.81% during the forecast period to surpass USD 2,459.74 million by the end of 2030. The major market participants in the market are proactively dealing with R&D for improving and propelling methods for tumor ablation. Moreover, there are likewise a few dangers related to the radiofrequency removal method, for example, hyperesthesia, shallow skin contaminations over the infusion site, heat harm to structures contiguous to the objective nerve, hypersensitive response to the sedative used to numb the skin, and that's only the tip of the iceberg.
The developing pervasiveness of disease is expanding the interest for compelling treatment. Unreasonable smoking and utilization of liquor and tobacco are the significant variables answerable for the rising predominance of malignant growth across the world. Expanding commonness of disease across the globe goes about as a significant driver in the worldwide tumor ablation market from 2021-to to 2030. Nonetheless, incidental effects and entanglement related to tumor ablation thwart the development of the worldwide tumor ablation market during the gauge time frame. Rising R&D exercises in tumor ablation are supposed to set out freedom in the worldwide tumor ablation market.
Market Segmentation
The market segmentation of the global tumor ablation market is carried out in terms of technology, treatment, application, and end-user.
The application segment of the global tumor ablation market is categorized into liver cancer, lung cancer, kidney cancer, and others. The treatment type divides the market based on surgical ablation, and percutaneous ablation laparoscopic ablation. Europe is the second-biggest market for growth ablation because of the development of normalized strategies and instruments for cancer ablation therapy, developing interest in medical procedure radiotherapy and chemotherapy for early recognized growths, and expanding instances of different cancer among the mid-matured and geriatric populace, and rising utilization of undesirable and cancer-causing items.
Regional Analysis
Geographically, the global tumor ablation market spans North America, Europe, Asia-Pacific, Rest of the World.
North America contributed the largest market of 40.29% in 2020 and is anticipated to lead the market during the review period. The regional market is driven by the advances in percutaneous ablation, developing interest in radiofrequency ablation for hepatocellular carcinoma, expanding geriatric populace, and development of cancer-related issues among the populace matured 65 years or more.
Europe is the second-biggest market for growth ablation because of the development of normalized strategies and instruments for cancer ablation therapy, developing interest in medical procedure radiotherapy and chemotherapy for early recognized growths, and expanding instances of different cancer among the mid-matured and geriatric populace, and rising utilization of undesirable and cancer-causing items. Asia-Pacific is supposed to fill essentially in the growth ablation market inferable from the rising utilization of cancer-causing items, for example, liquor and betel nut, restricted admission of leafy foods, a disclosure to indoor and open-air contamination, and ascend in openness to compound poisons across the region.
Key Competitors
The key players operating in the global tumor ablation include SonaCare Medical, LLC (US), Medtronic plc (Ireland), EDAP TMS (France), Angio Dynamics (US), HealthTronics, Inc (US), Johnson & Johnson (US), Boston Scientific Corporation (US), Misonix Inc (US), HistoSonics, Inc (US), Biotronik (Germany).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Companies Mentioned
SonaCare Medical
LLC (US)
Medtronic plc (Ireland)
EDAP TMS (France)
Angio Dynamics (US)
HealthTronics Inc (US)
Johnson & Johnson (US)
Boston Scientific Corporation (US)
Misonix Inc (US)
HistoSonics Inc (US)
Biotronik (Germany)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Tumor Ablation Market—Forecast till 2030
Market Overview
As per the MRFR analysis, the global tumor ablation market is estimated to witness a notable CAGR of 11.81% during the forecast period to surpass USD 2,459.74 million by the end of 2030. The major market participants in the market are proactively dealing with R&D for improving and propelling methods for tumor ablation. Moreover, there are likewise a few dangers related to the radiofrequency removal method, for example, hyperesthesia, shallow skin contaminations over the infusion site, heat harm to structures contiguous to the objective nerve, hypersensitive response to the sedative used to numb the skin, and that's only the tip of the iceberg.
The developing pervasiveness of disease is expanding the interest for compelling treatment. Unreasonable smoking and utilization of liquor and tobacco are the significant variables answerable for the rising predominance of malignant growth across the world. Expanding commonness of disease across the globe goes about as a significant driver in the worldwide tumor ablation market from 2021-to to 2030. Nonetheless, incidental effects and entanglement related to tumor ablation thwart the development of the worldwide tumor ablation market during the gauge time frame. Rising R&D exercises in tumor ablation are supposed to set out freedom in the worldwide tumor ablation market.
Market Segmentation
The market segmentation of the global tumor ablation market is carried out in terms of technology, treatment, application, and end-user.
The application segment of the global tumor ablation market is categorized into liver cancer, lung cancer, kidney cancer, and others. The treatment type divides the market based on surgical ablation, and percutaneous ablation laparoscopic ablation. Europe is the second-biggest market for growth ablation because of the development of normalized strategies and instruments for cancer ablation therapy, developing interest in medical procedure radiotherapy and chemotherapy for early recognized growths, and expanding instances of different cancer among the mid-matured and geriatric populace, and rising utilization of undesirable and cancer-causing items.
Regional Analysis
Geographically, the global tumor ablation market spans North America, Europe, Asia-Pacific, Rest of the World.
North America contributed the largest market of 40.29% in 2020 and is anticipated to lead the market during the review period. The regional market is driven by the advances in percutaneous ablation, developing interest in radiofrequency ablation for hepatocellular carcinoma, expanding geriatric populace, and development of cancer-related issues among the populace matured 65 years or more.
Europe is the second-biggest market for growth ablation because of the development of normalized strategies and instruments for cancer ablation therapy, developing interest in medical procedure radiotherapy and chemotherapy for early recognized growths, and expanding instances of different cancer among the mid-matured and geriatric populace, and rising utilization of undesirable and cancer-causing items. Asia-Pacific is supposed to fill essentially in the growth ablation market inferable from the rising utilization of cancer-causing items, for example, liquor and betel nut, restricted admission of leafy foods, a disclosure to indoor and open-air contamination, and ascend in openness to compound poisons across the region.
Key Competitors
The key players operating in the global tumor ablation include SonaCare Medical, LLC (US), Medtronic plc (Ireland), EDAP TMS (France), Angio Dynamics (US), HealthTronics, Inc (US), Johnson & Johnson (US), Boston Scientific Corporation (US), Misonix Inc (US), HistoSonics, Inc (US), Biotronik (Germany).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Companies Mentioned
SonaCare Medical
LLC (US)
Medtronic plc (Ireland)
EDAP TMS (France)
Angio Dynamics (US)
HealthTronics Inc (US)
Johnson & Johnson (US)
Boston Scientific Corporation (US)
Misonix Inc (US)
HistoSonics Inc (US)
Biotronik (Germany)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Table of Contents
85 Pages
- 1 Executive Summary
- 1.1.1 Market Synopsis
- 2 Market Introduction
- 2.1 Scope Of The Study
- 2.2 Research Objective
- 2.3 List Of Assumptions & Limitations
- 3 Research Methodology
- 3.1 Data Mining
- 3.2 Secondary Research
- 3.3 Primary Research
- 3.3.1 Primary Interviews And Information Gathering Process
- 3.3.2 Breakdown Of Primary Respondents
- 3.4 Forecasting Techniques
- 3.5 Research Methodology For Market Size Estimation
- 3.5.1 Bottom-up Approach
- 3.5.2 Top-down Approach
- 3.6 Data Triangulation
- 3.7 Validation
- 4 Market Dynamics
- 4.1 Overview
- 4.2 Drivers
- 4.2.1 Increasing Prevalence Of Cancer Across The Globe
- 4.2.2 Rising Demand For Minimally Invasive Tumor Ablation Techniques
- 4.2.3 Growing Number Of Public-private Initiatives And Funding To Support Ongoing Research Activities Related To Tumor Ablation
- 4.3 Restraints
- 4.3.1 Side-effects And Complications Associated With Tumor Ablation
- 4.3.2 Delay In Approval And Unfavorable Regulatory Policy And Reimbursement Scenario
- 4.4 Opportunity
- 4.4.1 Rising R&D Activities
- 5 Market Factor Analysis
- 5.1 Value Chain Analysis
- 5.1.1 R&D
- 5.1.2 Manufacturing
- 5.1.3 Distribution & Sales
- 5.1.4 Post-sales Monitoring
- 5.2 Porter's Five Forces Analysis
- 5.2.1 Threat Of New Entrants
- 5.2.2 Bargaining Power Of Suppliers
- 5.2.3 Bargaining Power Of Buyers
- 5.2.4 Threat Of Substitutes
- 5.2.5 Intensity Of Rivalry
- 5.3 Covid-19 Impact Analysis
- 5.3.1 Impact On Availability Of Surgical Facilities
- 5.3.2 Impact On Key Players
- 5.3.3 Impact On Clinical Trials
- 5.3.4 Impact On Supply Chain
- 6 Global Tumor Ablation Market, By Technology
- 6.1 Overview
- 6.2 Radiofrequency
- 6.3 Microwave
- 6.4 Irreversible Electroporation
- 6.5 Cryoablation
- 6.6 Others
- 7 Global Tumor Ablation Market, By Treatment
- 7.1 Overview
- 7.2 Surgical Ablation
- 7.3 Percutaneous Ablation
- 7.4 Laparoscopic Ablation
- 8 Global Tumor Ablation Market, By Application
- 8.1 Overview
- 8.2 Lung Cancer
- 8.3 Kidney Cancer
- 8.4 Liver Cancer
- 8.5 Others
- 9 Global Tumor Ablation Market, By End User
- 9.1 Overview
- 9.2 Hospital And Clinics
- 9.3 Speciality Centers
- 9.4 Others
- 10 Global Tumor Ablation Market, By Region
- 10.1 Overview
- 10.2 North America
- 10.2.1 Us
- 10.2.2 Canada
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 France
- 10.3.3 Uk
- 10.3.4 Italy
- 10.3.5 Spain
- 10.3.6 Rest Of Europe
- 10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 India
- 10.4.3 Japan
- 10.4.4 South Korea
- 10.4.5 Australia
- 10.4.6 Rest Of Asia Pacific
- 10.5 Rest Of The World
- 10.5.1 Middle East
- 10.5.2 Africa
- 10.5.3 Latin America
- 11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Benchmarking
- 11.3 Major Growth Strategy In The Global Tumor Ablation Market
- 11.4 The Leading Player In Terms Of The Number Of Developments In The Global Tumor Ablation Market
- 11.5 Key Development Analysis
- 11.6 Key Developments & Growth Strategies
- 11.6.1 Product Launch/Product Approval
- 11.6.2 Merger &Acquisition
- 11.7 Financial Matrix
- 11.7.1 Sales (Usd Million), 2020
- 11.7.2 R&D Expenditure (Usd Million), 2020
- 12 Drg Cost Of Curative Treatment
- 12.1 Diagnosis-related Group (Drg)
- 12.2 Biopsy Procedure Reimbursement
- 12.3 Ablation Procedure Reimbursment
- 12.3.1 Liver Ablation Procedure Reimbursment
- 12.3.2 Kidney Ablation Procedure Reimbursment
- 12.3.3 Lung Ablation Procedure Reimbursment
- 12.4 Imaging Procedure Reimbursment
- 12.5 Total Curative Treatment Costs
- 13 Company Profiles
- 13.1 Sonacare Medical
- 13.1.1 Company Overview
- 13.1.2 Financial Overview
- 13.1.3 Products/Services Offered
- 13.1.4 Key Developments
- 13.1.5 Swot Analysis
- 13.1.6 Key Strategies
- 13.2 Medtronic Plc
- 13.2.1 Company Overview
- 13.2.2 Financial Overview
- 13.2.3 Products/Services Offered
- 13.2.4 Key Developments
- 13.2.5 Swot Analysis
- 13.2.6 Key Strategies
- 13.3 Edap Tms
- 13.3.1 Company Overview
- 13.3.2 Financial Overview
- 13.3.3 Products/Services Offered
- 13.3.4 Key Developments
- 13.3.5 Swot Analysis
- 13.3.6 Key Strategies
- 13.4 Angiodynamics
- 13.4.1 Company Overview
- 13.4.2 Financial Overview
- 13.4.3 Products/Services Offered
- 13.4.4 Key Developments
- 13.4.5 Swot Analysis
- 13.4.6 Key Strategies
- 13.5 Healthtronics, Inc.
- 13.5.1 Company Overview
- 13.5.2 Financial Overview
- 13.5.3 Products/Services Offered
- 13.5.4 Key Developments
- 13.5.5 Swot Analysis
- 13.5.6 Key Strategies
- 13.6 Johnson & Johnson
- 13.6.1 Company Overview
- 13.6.2 Financial Overview
- 13.6.3 Products/Services Offered
- 13.6.4 Key Developments
- 13.6.5 Swot Analysis
- 13.6.6 Key Strategies
- 13.7 Boston Scientific Corporation
- 13.7.1 Company Overview
- 13.7.2 Financial Overview
- 13.7.3 Products/Services Offered
- 13.7.4 Key Developments
- 13.7.5 Swot Analysis
- 13.7.6 Key Strategies
- 13.8 Misonix, Inc.
- 13.8.1 Company Overview
- 13.8.2 Financial Overview
- 13.8.3 Products/Services Offered
- 13.8.4 Key Developments
- 13.8.5 Swot Analysis
- 13.8.6 Key Strategies
- 13.9 Histosonics, Inc.
- 13.9.1 Company Overview
- 13.9.2 Financial Overview
- 13.9.3 Products/Services Offered
- 13.9.4 Key Developments
- 13.9.5 Swot Analysis
- 13.9.6 Key Strategies
- 13.10 Biotronik
- 13.10.1 Company Overview
- 13.10.2 Financial Overview
- 13.10.3 Products/Services Offered
- 13.10.4 Key Developments
- 13.10.5 Swot Analysis
- 13.10.6 Key Strategies
- 14 Appendix
- 14.1 References
- 14.2 Related Reports 120
- List Of Tables
- Table 1 List Of Assumptions & Limitations
- Table 2 Global Tumor Ablation Market, By Technology, 2018–2030 (Usd Million)
- Table 3 Global Tumor Ablation Market, For Radiofrequency, By Region, 2018–2030 (Usd Million)
- Table 4 Global Tumor Ablation Market, For Microwave, By Region, 2018–2030 (Usd Million)
- Table 5 Global Tumor Ablation Market, For Irreversible Electroporation, By Region, 2018–2030 (Usd Million)
- Table 6 Global Tumor Ablation Market, For Cryoablation, By Region, 2018–2030 (Usd Million)
- Table 7 Global Tumor Ablation Market, For Others, By Region, 2018–2030 (Usd Million)
- Table 8 Global: Tumor Ablation Market, By Treatment, 2018–2030 (Usd Million)
- Table 9 Global: Tumor Ablation Market For Surgical Ablation, By Region, 2018–2030 (Usd Million)
- Table 10 Global: Tumor Ablation Market, For Percutaneous Ablation, By Region, 2018–2030 (Usd Million)
- Table 11 Global: Tumor Ablation Market, For Laparoscopic Ablation, By Region, 2018–2030 (Usd Million)
- Table 12 Global: Tumor Ablation Market, By Application, 2018–2030 (Usd Million)
- Table 13 Global: Tumor Ablation Market For Lung Cancer, By Region, 2018–2030 (Usd Million)
- Table 14 5-year Relative Survival Rates For Kidney Cancer
- Table 15 Global: Tumor Ablation Market, For Kidney Cancer, By Region, 2018–2030 (Usd Million)
- Table 16 Global: Tumor Ablation Market, For Liver Cancer, By Region, 2018–2030 (Usd Million)
- Table 17 Global: Tumor Ablation Market, For Others, By Region, 2018–2030 (Usd Million)
- Table 18 Global: Tumor Ablation Market, By End User, 2018–2030 (Usd Million)
- Table 19 Global: Tumor Ablation Market For Hospital And Clinics, By Region, 2018–2030 (Usd Million)
- Table 20 Global: Tumor Ablation Market, For Speciality Centers, By Region, 2018–2030 (Usd Million)
- Table 21 Global: Tumor Ablation Market For Others, By Region, 2018–2030 (Usd Million)
- Table 22 Global: Tumor Ablation Market, By Region, 2018–2030 (Usd Million)
- Table 23 Estimated Number Of Us Cancer Survivors By Site (Male), 2020
- Table 24 Estimated Number Of Us Cancer Survivors By Site (Female), 2020
- Table 25 North America: Tumor Ablation Market, By Country, 2018–2030 (Usd Million)
- Table 26 North America: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 27 North America: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 28 North America: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 29 North America: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 30 Us: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 31 Us: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 32 Us: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 33 Us: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 34 Canada: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 35 Canada: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 36 Canada: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 37 Canada: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 38 Europe: Tumor Ablation Market, By Country, 2018–2030 (Usd Million)
- Table 39 Europe: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 40 Europe: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 41 Europe: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 42 Europe: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 43 Germany: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 44 Germany: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 45 Germany: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 46 Germany: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 47 France: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 48 France: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 49 France: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 50 France: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 51 Uk: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 52 Uk: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 53 Uk: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 54 Uk: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 55 Italy: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 56 Italy: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 57 Italy: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 58 Italy: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 59 Spain: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 60 Spain: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 61 Spain: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 62 Spain: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 63 Rest Of Europe: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 64 Rest Of Europe: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 65 Rest Of Europe: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 66 Rest Of Europe: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 67 Asia Pacific: Tumor Ablation Market, By Country, 2018–2030 (Usd Million)
- Table 68 Asia Pacific: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 69 Asia Pacific: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 70 Asia Pacific: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 71 Asia Pacific: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 72 China: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 73 China: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 74 China: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 75 China: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 76 India: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 77 India: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 78 India: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 79 India: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 80 Japan: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 81 Japan: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 82 Japan: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 83 Japan: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 84 South Korea: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 85 South Korea: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 86 South Korea: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 87 South Korea: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 88 Australia: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 89 Australia: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 90 Australia: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 91 Australia: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 92 Rest Of Asia Pacific: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 93 Rest Of Asia Pacific: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 94 Rest Of Asia Pacific: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 95 Rest Of Asia Pacific: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 96 Rest Of The World: Tumor Ablation Market, By Region, 2018–2030 (Usd Million)
- Table 97 Rest Of The World: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 98 Rest Of The World: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 99 Rest Of The World: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 100 Rest Of The World: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 101 Middle East: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 102 Middle East: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 103 Middle East: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 104 Middle East: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 105 Africa: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 106 Africa: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 107 Africa: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 108 Africa: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 109 Latin America: Tumor Ablation Market, By Technology, 2018-2030 (Usd Million)
- Table 110 Latin America: Tumor Ablation Market, By Treatment, 2018-2030 (Usd Million)
- Table 111 Latin America: Tumor Ablation Market, By Application, 2018-2030 (Usd Million)
- Table 112 Latin America: Tumor Ablation Market, By End User, 2018-2030 (Usd Million)
- Table 113 Major Players In The Global Tumor Ablation Market
- Table 114 Most Active Player In The Global Tumor Ablation Market
- Table 115 Product Launch/Product Approval
- Table 116 Merger &Acquisition
- Table 117 Biopsy Procedure Reimbursement (Usd), 2019
- Table 118 Liver Ablation Procedure Reimbursment (Usd), 2019
- Table 119 Kidney Ablation Procedure Reimbursment (Usd), 2019
- Table 120 Lung Ablation Procedure Reimbursment
- Table 121 Imaging Procedure Reimbursment
- Table 122 Total Curative Treatment Costs
- Table 123 Sonacare Medical: Products/Services Offered
- Table 124 Sonacare Medical: Key Developments
- Table 125 Medtronic Plc: Products/Services Offered
- Table 126 Edap Tms: Products/Services Offered
- Table 127 Angiodynamics: Products/Services Offered
- Table 128 Healthtronics, Inc.: Products/Services Offered
- Table 129 Johnson & Johnson: Products/Services Offered
- Table 130 Boston Scientific Corporation: Products/Services Offered
- Table 131 Boston Scientific Corporation: Key Developments
- Table 132 Misonix, Inc.: Products/Services Offered
- Table 133 Misonix, Inc.: Key Developments
- Table 134 Histosonics, Inc.: Products/Services Offered
- Table 135 Biotronik: Products/Services Offered
- List Of Figures
- Figure 1 Global Tumor Ablation Market Structure
- Figure 2 Bottom-up And Top-down Approaches
- Figure 3 Market Dynamics Analysis Of The Global Tumor Ablation Market
- Figure 4 Drivers: Impact Analysis
- Figure 5 Restraints: Impact Analysis
- Figure 6 Value Chain Analysis: Global Tumor Ablation Market
- Figure 7 Porter's Five Forces Analysis Of The Global Tumor Ablation Market
- Figure 8 Global Tumor Ablation Market Share, By Technology, 2020-2030 (Usd Million)
- Figure 9 Global: Tumor Ablation Market, By Treatment, 2020 & 2030 (Usd Million)
- Figure 10 Global: Tumor Ablation Market, By Application, 2020 & 2030 (Usd Million)
- Figure 11 Global: Tumor Ablation Market, By End User, 2020 & 2030 (Usd Million)
- Figure 12 Global: Tumor Ablation Market, By Region 2020 & 2030 (Usd Million)
- Figure 13 North America: Tumor Ablation Market Share, By Country 2020 (%)
- Figure 14 Europe, Number Of New Cancer Cases In 2020
- Figure 15 Europe: Tumor Ablation Market Share (%), By Country, 2020
- Figure 16 Asia Pacific: Tumor Ablation Market Share (%), By Region, 2020
- Figure 17 Rest Of The World, Number Of New Cancer Cases In 2020
- Figure 18 Rest Of The World: Tumor Ablation Market Share (%), By Region, 2020
- Figure 19 Benchmarking Of Major Competitors
- Figure 20 Major Strategy Adopted By Key Players In The Global Tumor Ablation Market
- Figure 21 Global Tumor Ablation Market: Competitive Landscape
- Figure 22 Sales (Usd Million), 2020
- Figure 23 R&D Expenditure (Usd Million), 2020
- Figure 24 Sonacare Medical: Swot Analysis
- Figure 25 Medtronic Plc: Financial Overview Snapshot
- Figure 26 Medtronic Plc: Swot Analysis
- Figure 27 Edap Tms: Financial Overview Snapshot
- Figure 28 Edap Tms: Swot Analysis
- Figure 29 Angiodynamics: Financial Overview Snapshot
- Figure 30 Angiodynamics: Swot Analysis
- Figure 31 Healthtronics, Inc.: Swot Analysis
- Figure 32 Johnson & Johnson: Financial Overview Snapshot
- Figure 33 Johnson & Johnson: Swot Analysis
- Figure 34 Boston Scientific Corporation: Financial Overview Snapshot
- Figure 35 Boston Scientific Corporation: Swot Analysis
- Figure 36 Misonix, Inc.: Financial Overview Snapshot
- Figure 37 Misonix, Inc.: Swot Analysis
- Figure 38 Histosonics, Inc.: Swot Analysis
- Figure 39 Biotronik: Swot Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
